Mirai Bio
Latest round
- Series A
Last raised
- Sep 2024
Total raised
- $50M
Investors
- 1
About Mirai Bio
Mirai Bio specializes in optimizing genetic medicine delivery systems. Founded by Hari Pujar, the company is headquartered in Cambridge, US.Mirai offers a platform designed to optimize the delivery of genetic medicines by leveraging machine learning and innovative lipid formulations. Their services include generative design that creates potent and targeted cargo for therapeutic agents, effectively reaching diverse tissues and cell types. The platform addresses limitations of current delivery systems, significantly advancing genome engineering, tRNA, mRNA, and DNA therapeutics.Mirai generates revenue through strategic partnerships with biotech companies, using a business-to-business (B2B) model. Revenue is derived from project-based fees, milestone payments, and potential royalties from successful commercialization of therapies developed through these collaborations. Their offerings, centered around machine-learning optimized delivery vehicles, are vital for maximizing therapeutic efficacy while facilitating market entry. The company plans to explore new markets, particularly in Europe and Asia, with a focus on establishing partnerships by the end of 2025.
Who invested in Mirai Bio
1 investor across 1 round
See all investors in Mirai Bio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 26, 2024
Amount
$50M
Investors
Questions about Mirai Bio
Who invested in Mirai Bio?
Mirai Bio has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Mirai Bio raised?
Mirai Bio has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Mirai Bio last raise money?
Mirai Bio's most recent round on record is a Series A, in Sep 2024.
What does Mirai Bio do?
Mirai Bio specializes in optimizing genetic medicine delivery systems.
Where is Mirai Bio headquartered?
Mirai Bio is headquartered in Cambridge, US.
Which VCs invest in companies like Mirai Bio?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Mirai Bio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Mirai Bio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.